Status:
UNKNOWN
Pre-therapeutic Analysis of the Individual Radiosensitivity of Cancer Patients in Luxembourg (APRI-Lux): Prospective National Interventional Study With Minimal Risk
Lead Sponsor:
Centre Francois Baclesse, Luxembourg
Collaborating Sponsors:
BIONEXT
Neolys
Conditions:
Radiosensitivity
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pre-therapeutic analysis of the individual radiosensitivity of cancer patients in Luxembourg
Eligibility Criteria
Inclusion
- Patient over 18 years old
- Patient with an indication for curative radiotherapy
- Patient having given his signed written informed consent before any specific procedure of the protocol.
Exclusion
- Patient with a contraindication to radiotherapy
- Patient with an indication for palliative radiotherapy
- Patient with a history of radiotherapy in the area where the cancer is located
- Patient unable to submit to the medical follow-up of the trial for geographical, social or psychological reasons.
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05433974
Start Date
October 1 2022
End Date
June 1 2024
Last Update
June 27 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.